Skip to main content

Dr Chrissie Thirlwell

Royal Free Hospital

Chrissie is a Senior Lecturer and Consultant in Medical Oncology at the Royal Free Hospital Neuroendocrine tumour (NET) Unit and University College London Cancer Institute. She is the NET GeCIP domain lead and was delighted to take on the role of the 100,000 Genomes Cancer arm representative on the GeCIP board in July 2018.

She is also Chair of the UK and Ireland Neuroendocrine Tumour Society (UKINETS) Research Committee, Scientific Board member of the NET Research Foundation (USA), European Society of Medical Oncology (ESMO) NET faculty member and Undergraduate academic lead at the UCL Cancer Institute.

Chrissie has 15 years of experience working in cancer genomics. Her PhD in colorectal cancer genetics was funded by the Medical Research Council, following this she completed her Medical Oncology training while holding a National Institute of Health Research Clinical Lecturer post, until her appointment as Consultant in 2010.

Chrissie leads a research group at the UCL Cancer Institute and has a particular interest in integrated genomic and circulating free DNA analysis of neuroendocrine tumors and other cancers with the aim of identifying novel therapeutic targets and personalising therapy. To-date she has successfully identified sub-groups of NETs with poorer clinical outcomes, and has successfully isolated and sequenced DNA from circulating DNA and NET cells in the bloodstream (CTCs). She has delivered plenary lectures at UK, European and North American NET meetings, and received national and international prizes and awards for research undertaken by her team.

Explore Genomics England